Levalbuterol_hydrochloride: profile and news

Sepracor Receives Notice of Second Abbreviated New Drug ...  Jan 12, 2006
FDA) has received an abbreviated new drug application (ANDA) from Dey, LP for a generic version of levalbuterol hydrochloride inhalation solution. ... - Business Wire (press release),

Sepracor Announces Fourth Quarter and Full Year 2005 Results ...  Jan 31, 2006
...that the FDA received an abbreviated new drug application (ANDA) from Breath Limited for a generic version of levalbuterol hydrochloride inhalation solution. ... - Genetic Engineering News,

Sepracor Receives Notice of Second Abbreviated New Drug ...  Jan 12, 2006
Administration (FDA) hasreceived an abbreviated new drug application (ANDA) from Dey, LP fora generic version of levalbuterol hydrochloride inhalation solution ... - Finanzen.net,

Sepracor to defend Xopenx patents  Jan 12, 2006
Merck KGaA -- had filed a generic drug application with the Food and Drug Administration for a version of inhalable levalbuterol hydrochloride, the active ... - BusinessWeek

Sepracor Announces Third Quarter 2005 Operating Results  Oct 25, 2005
FDA) received an abbreviated new drug application (ANDA) from Breath Limited for a generic version of levalbuterol hydrochloride inhalation solution. ... - Business Wire (press release),

Sepracor patents are challenged  08 Sep 2005
...has received an abbreviated new drug application (ANDA) from Breath Limited for a generic version of levalbuterol hydrochloride inhalation solution. ... - Boston Mass High Tech,

Sepracor Receives Notice of Abbreviated New Drug Application ...  Sep 7, 2005
FDA) has received an abbreviated new drug application (ANDA) from Breath Limited for a generic version of levalbuterol hydrochloride inhalation solution. ... - Business Wire (press release),